Gilead vs Gilead: Indian court restrains 'infringer'
This article was originally published in Scrip
Executive Summary
This one for sure would have left Gilead Sciences stunned. The US firm, which sought to register a subsidiary by the name of Gilead Sciences Private Ltd in India earlier this year, has found to its dismay that such a company already exists in the country.
You may also be interested in...
Sun Wards Off Volini Infringers, Makes It Count Too
Sun Pharma has blocked a group of firms attempting to ride on the trademark of its popular pain relief brand Volini – among the key products at the core of the Indian firm’s OTC business.
Sun Wards Off Volini Infringers, Makes It Count Too
Sun Pharma has blocked a group of firms attempting to ride on the trademark of its popular pain relief brand Volini – among the key products at the core of the Indian firm’s OTC business.
How Sanofi Is ‘Playing To Win’ In India, Watch Diabetes Space
Sanofi India managing director Rodolfo Hrosz talks to Scrip about the company’s refreshed India strategy including in the competitive diabetes segment, which is expected to see a flurry of new product activity. While Soliqua has hit the market, all eyes are also on Novo Nordisk’s Awiqli and Cipla’s partnered inhaled insulin in the wings.